We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Innovative Gel Offers Revolutionary Treatment for Challenging Gastrointestinal Leaks

By HospiMedica International staff writers
Posted on 01 Dec 2023
Print article
Image: The gel has been developed for sealing and healing challenging gastrointestinal tract-to-skin connections (Photo courtesy of Terasaki Institute)
Image: The gel has been developed for sealing and healing challenging gastrointestinal tract-to-skin connections (Photo courtesy of Terasaki Institute)

Gastrointestinal leaks, medically referred to as enterocutaneous fistulas, are abnormal pathways between the gastrointestinal tract and the skin, often resulting from surgical complications. This condition leads to the leakage of intestinal and stomach contents through to the skin, posing severe health threats such as skin damage, heightened infection risk, and high mortality rates, estimated at 15-20%. The primary treatment for this involves extensive surgery, aiming to restore bowel function, excise the fistula, and reconnect the bowel ends, followed by securing the abdominal wall. This underscores the pressing need for less invasive treatment options for sealing and healing these gastrointestinal leaks.

In a significant breakthrough, researchers at the Terasaki Institute for Biomedical Innovation (Los Angeles, CA, USA) have created an innovative adhesive gel designed to address gastrointestinal leaks. This novel treatment represents a substantial leap forward in managing a condition that has long presented challenges to both patients and healthcare providers. The gel is formulated from a combination of synthetic nanoparticles and gelatin altered with dopamine, enabling it to solidify rapidly upon injection. This rapid solidification forms a durable, adhesive structure, effectively sealing off the fistula and preventing further health complications while promoting healing.

The gel's standout feature is its ability to be easily injected and quickly form a stable structure, which is key in facilitating tissue regeneration and harmonizing with adjacent tissues. This attribute is especially beneficial in medical scenarios where precision and less invasive methods are crucial. Moreover, the gel has exhibited exceptional biocompatibility in animal studies. It encourages cell growth and the deposition of vital proteins for new tissue formation, essential aspects of the healing process. Importantly, the gel accomplishes these healing steps without causing fibrotic tissue formation, often a challenge in tissue repair methods. This research holds promise not only for the direct treatment of gastrointestinal leaks but also for broader applications in tissue engineering and regenerative medicine. The innovative approach and technologies developed through this research may pave the way for new therapeutic strategies across various medical fields.

Related Links:
Terasaki Institute 

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Digital Radiography System
DigiEye 680
New
Neonatal and Pediatric Tracheostomy Tubes
Portex Bivona FlexTend TTS Tracheostomy Tubes

Print article

Channels

Surgical Techniques

view channel
Image: The KeyScope low-cost laparoscope enables high resolution surgical imaging (Photo courtesy of Barnes et al., doi 10.1117/1.BIOS.2.2.022302)

Low-Cost, Robust Laparoscope Addresses Cost, Power and Sterilization Challenges

Laparoscopic surgery, a minimally invasive technique, has revolutionized surgical practices in high-income countries. This method involves using a laparoscope to perform operations through small incisions,... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.